Home | Symbol Index | About |

Generex Biotechnology Corporati (GNBT)

Generex Biotechnology Corporati is related to 5 other symbols. To date we've encountered 141 releases involving Generex Biotechnology Corporati.

Last Price: 0.3499 (+0.0398) - 1/7/2009, 3:59pm

Open: 0.32
High: 0.39
Low: 0.31

Generex Biotechnology Corporati Options

Generex Biotechnology Corporati "Business Partners"

Generex Biotechnology Corporati Press Releases

Generex Biotechnology Corporati News

Generex Biotechnology Corporati Contact

Generex Biotechnology Corporati Related (via TRYNT)

Generex Biotechnology Corporati "Business Partners"

A "business partner" is defined as a third party company that has co-released at least one press release with Generex Biotechnology Corporati.

Generex Biotechnology Corporati Press Releases

Generex Biotechnology Corporation: Generex Biotechnology to Make Podium Presentation at the World Congress on Controversies in Obesity, Diabetes and Hypertension (Trackbacks) (Backlinks), Thu, 26 Oct 2006 8:15:00 PDT
TORONTO (MARKET WIRE) Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that Dr. Gerald Bernstein, the Company's Vice-President for Medical Affairs, will make a podium presentation at The World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy) (www.codhy.com) to be held in Berlin, Germany, October 26 - 29,
Generex Biotechnology: Generex Biotechnology CEO to Present at The C.E. Unterberg, Towbin Life Sciences Conference (Trackbacks) (Backlinks), Wed, 25 Oct 2006 4:00:00 PDT
TORONTO (MARKET WIRE) Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that Anna Gluskin, the Company's President & Chief Executive Officer, will be presenting at The C.E. Unterberg, Towbin Life Sciences Conference in New York City, October 30 - 31, 2006. Ms. Gluskin's presentation is scheduled for 1 p.m. (EST) on Monday, October 30,
Generex Biotechnology: Generex Biotechnology Co-Hosts Diabetes Symposium (Trackbacks) (Backlinks), Mon, 23 Oct 2006 11:05:00 PDT
TORONTO (MARKET WIRE) On October 20, 2006, Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, together with University Campus Bio-Medico of Rome, Italy, hosted a symposium as an adjunct to the Canadian Diabetes Association Professional Conference and Annual Meetings in Toronto, Canada.
Generex Biotechnology: Generex Biotechnology Has Strong Presence at Annual Canadian Diabetes Association Conference (Trackbacks) (Backlinks), Thu, 19 Oct 2006 7:25:00 PDT
TORONTO (MARKET WIRE) Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, will make a podium presentation today at the 2006 Canadian Diabetes Association (CDA) Professional Conference and Annual Meetings in Toronto, Canada. The presentation, to be made by Dr. Gerald Bernstein, the Company's Vice-President for Medical Affairs, relates to Generex
Generex Biotechnology Corporation: Generex Biotechnology Announces Filing of Its Form 10-K Annual Report for the Fiscal Year Ended July 31, 2006 (Trackbacks) (Backlinks), Tue, 17 Oct 2006 6:15:00 PDT
TORONTO (MARKET WIRE) Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has filed its Form 10-K Annual Report for the fiscal year of the Company ended July 31, 2006 with the United States Securities and Exchange Commission.
Generex Biotechnology: Generex Biotechnology Announces Expansion of Glucose RapidSpray(TM) Distribution (Trackbacks) (Backlinks), Tue, 10 Oct 2006 5:00:00 PDT
TORONTO (MARKET WIRE) Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in metabolic diseases drug delivery through the inner lining of the mouth, announced today that it has filled several purchase orders from additional retail pharmacies for Glucose RapidSpray, its new over-the-counter glucose oral spray product.
Generex Biotechnology: Generex Biotechnology Announces Glucose RapidSpray(TM) Product to Be Available at Shoppers Drug Mart(R) (Trackbacks) (Backlinks), Wed, 4 Oct 2006 6:40:00 PDT
TORONTO (MARKET WIRE) Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in metabolic diseases drug delivery through the inner lining of the mouth, announced today that the Company's new Glucose RapidSpray™ product will be available in Shoppers Drug Mart® stores across Canada (Pharmaprix® in Québec) in late October, 2006.
Generex Biotechnology: Generex Biotechnology Publishes Studies Demonstrating Anti-Tumor Potential of Immunotherapeutic Vaccine (Trackbacks) (Backlinks), Tue, 3 Oct 2006 4:00:00 PDT
TORONTO (MARKET WIRE) Generex Biotechnology Corporation (NASDAQ: GNBT) announced today publication of studies demonstrating specific anti-tumor activity of its novel Ii-Key/HER-2/neu immunotherapeutic vaccine. The studies were performed in the laboratory of Dr. Costas Baxevanis in collaboration with scientists at Antigen Express, the immunotherapeutic division of Generex Biotechnology.
Generex Biotechnology: Torc Investments and Research Initiates Coverage of Generex Biotechnology With a Buy Rating and 12-Month Price Target of $3.00-$3.50 (Trackbacks) (Backlinks), Wed, 27 Sep 2006 6:35:00 PDT
TORONTO (MARKET WIRE) Generex Biotechnology Corporation (NASDAQ: GNBT) announced today that Torc Investments and Research LLC, a NASD registered broker-dealer, initiated research coverage of the Company today with a Buy rating and a 12-month price target of $3-$3.50.
Generex Biotechnology: Generex Biotechnology Supported Research Has Podium Presentation at the 42nd Annual Meeting of the European Association for the Study of Diabetes (Trackbacks) (Backlinks), Tue, 19 Sep 2006 6:15:00 PDT
TORONTO (MARKET WIRE) Generex Biotechnology Corporation (NASDAQ: GNBT) announced today that internationally renowned diabetes investigators Professor Paolo Pozzilli and Dr. Marta Vadacca, both of the Department of Endocrinology and Diabetes at University Campus Bio-Medico, Rome, Italy, made a podium presentation of the results of a research project sponsored by Antigen Express, Inc., a wholly owned subsidiary of the Company, at the

Generex Biotechnology Corporati News

Generex Announces Governmental Approval of its Oral Insulin Spray Product in Lebanon (GlobeNewswire), Tue, 23 Dec 2008 13:35:00 Etc/GMT
GENEREX BIOTECHNOLOGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E (EDGAR Online), Tue, 23 Dec 2008 13:31:40 Etc/GMT
Generex Biotechnology and Pevion Biotech Announce Plans for Immunotherapeutic Vaccine Collaboration (GlobeNewswire), Tue, 16 Dec 2008 14:00:00 Etc/GMT
Generex Awarded New Patent in Europe (GlobeNewswire), Mon, 15 Dec 2008 14:30:00 Etc/GMT
Genentech and Generex: New HER2/neu Research (at Seeking Alpha), Mon, 15 Dec 2008 12:39:36 Etc/GMT
GENEREX BIOTECHNOLOGY CORP Financials (EDGAR Online Financials), Sat, 13 Dec 2008 14:04:18 Etc/GMT
Generex Biotechnology Update On Novel Immunotherapeutic Vaccine to be Presented At San Antonio Breast Cancer Symposium (GlobeNewswire), Thu, 11 Dec 2008 15:03:49 Etc/GMT
GENEREX BIOTECHNOLOGY CORP Files SEC form 10-Q, Quarterly Report (EDGAR Online), Tue, 9 Dec 2008 21:43:48 Etc/GMT
Generex Announces Positive Results of Metformin Chewing Gum Trial (GlobeNewswire), Tue, 2 Dec 2008 14:30:00 Etc/GMT
As diabetes surges, the search for better treatments intensifies (at MarketWatch), Tue, 25 Nov 2008 21:33:00 Etc/GMT
Generex Updates On Press Coverage of Generex Oral-lyn(tm) Commercial Launch in India (GlobeNewswire), Tue, 25 Nov 2008 14:00:00 Etc/GMT
[$$] Biotech Mailbag: Recap on GenVec (at RealMoney by TheStreet.com), Fri, 21 Nov 2008 12:45:59 Etc/GMT
Generex Awarded New Pain Relief Patents (GlobeNewswire), Wed, 19 Nov 2008 15:16:33 Etc/GMT
Photo Release -- Generex Launches Oral Insulin for Diabetes Management in India; Retail Availability Coincides With World Diabetes Day (GlobeNewswire), Fri, 14 Nov 2008 14:30:00 Etc/GMT
CORRECTION -- Generex Biotechnology to Make Convertible Debenture Payment in Cash (GlobeNewswire), Wed, 12 Nov 2008 17:00:23 Etc/GMT
Generex Biotechnology to Make Convertible Debenture Payment in Cash (GlobeNewswire), Wed, 12 Nov 2008 13:00:00 Etc/GMT
Generex Biotechnology Corporation's Antigen Express Subsidiary Featured in Technology Update and Value Focus Review Issued by Scimitar Equity, LLC (GlobeNewswire), Mon, 10 Nov 2008 14:00:00 Etc/GMT
Generex Oral-lyn(tm) Featured On XM Satellite Radio (GlobeNewswire), Wed, 5 Nov 2008 16:00:00 Etc/GMT
Generex Biotechnology Submits Syrian Dossier (GlobeNewswire), Wed, 5 Nov 2008 12:00:00 Etc/GMT
Generex Oral-lyn Featured at International Diabetes Conference (GlobeNewswire), Tue, 4 Nov 2008 13:00:00 Etc/GMT

Generex Biotechnology Corporati Contact

Contacts:
Shayne Gilliatt
Generex Biotechnology Corporation
Phone: (800) 391-6755
or (416) 364-2551

Andrew Hellman
CEOcast, Inc.
Phone: (212) 732-4300

Dolores Naney
Rubenstein Public Relations
Phone: (212) 843-8018

TRYNT Related

TRYNT did not suggest any related symbols

What is a Stock Cloud?

A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.